Annual ROE
201.12%
-336.38%-62.58%
July 31, 2024
Summary
- As of February 7, 2025, BCTX annual return on equity is 201.12%, with the most recent change of -336.38% (-62.58%) on July 31, 2024.
- During the last 3 years, BCTX annual ROE has risen by +251.05% (+502.80%).
- BCTX annual ROE is now -99.97% below its all-time high of 740.57 thousand%, reached on July 31, 2014.
Performance
BCTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
536.28%
+396.37%+283.30%
October 31, 2024
Summary
- As of February 7, 2025, BCTX quarterly return on equity is 536.28%, with the most recent change of +396.37% (+283.30%) on October 31, 2024.
- Over the past year, BCTX quarterly ROE has increased by +377.38% (+237.50%).
- BCTX quarterly ROE is now -95.93% below its all-time high of 13.19 thousand%, reached on July 31, 2023.
Performance
BCTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
BCTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.6% | +237.5% |
| 3 y3 years | +502.8% | +756.4% |
| 5 y5 years | -70.6% | +756.4% |
BCTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -62.6% | +177.4% | -95.9% | +198.7% |
| 5 y | 5-year | -70.6% | +177.4% | -95.9% | +198.7% |
| alltime | all time | -100.0% | +145.8% | -95.9% | +138.0% |
BriaCell Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | 536.28%(+283.3%) |
| Jul 2024 | 201.12%(-62.6%) | 139.91%(-12.0%) |
| Apr 2024 | - | 158.90%(-52.7%) |
| Jan 2024 | - | 335.72%(-47.7%) |
| Oct 2023 | - | 641.38%(-95.1%) |
| Jul 2023 | 537.50%(-306.9%) | 13.19 K%(-2525.9%) |
| Apr 2023 | - | -543.62%(+277.8%) |
| Jan 2023 | - | -143.89%(+9892.4%) |
| Oct 2022 | - | -1.44%(-97.9%) |
| Jul 2022 | -259.84%(+420.4%) | -67.42%(-30.0%) |
| Apr 2022 | - | -96.27%(+17.8%) |
| Jan 2022 | - | -81.70%(-53.5%) |
| Oct 2021 | - | -175.56%(+9.6%) |
| Jul 2021 | -49.93%(-144.6%) | -160.23%(-197.0%) |
| Apr 2021 | - | 165.11%(+159.4%) |
| Jan 2021 | - | 63.65%(-42.5%) |
| Oct 2020 | - | 110.60%(-37.1%) |
| Jul 2020 | 111.87%(-83.7%) | 175.73%(-40.9%) |
| Apr 2020 | - | 297.44%(-57.6%) |
| Jan 2020 | - | 701.45%(-51.1%) |
| Oct 2019 | - | 1434.17%(-78.5%) |
| Jul 2019 | 684.30%(-255.7%) | 6670.18%(-573.0%) |
| Apr 2019 | - | -1410.23%(+119.4%) |
| Jan 2019 | - | -642.74%(+47.8%) |
| Oct 2018 | - | -434.87%(+23.4%) |
| Jul 2018 | -439.60%(+27.6%) | -352.44%(+9.3%) |
| Apr 2018 | - | -322.56%(-6.0%) |
| Jan 2018 | - | -343.03%(+44.5%) |
| Oct 2017 | - | -237.33%(+20.9%) |
| Jul 2017 | -344.45%(+59.9%) | -196.31%(+50.2%) |
| Apr 2017 | - | -130.67%(+30.7%) |
| Jan 2017 | - | -99.94%(-37.4%) |
| Oct 2016 | - | -159.77%(-17.3%) |
| Jul 2016 | -215.42%(-6.9%) | -193.09%(+22.7%) |
| Apr 2016 | - | -157.38%(+7.8%) |
| Jan 2016 | - | -146.03%(-32.3%) |
| Oct 2015 | - | -215.69%(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2015 | -231.37%(-100.0%) | -206.71%(-80.1%) |
| Apr 2015 | - | -1036.39%(+167.6%) |
| Jan 2015 | - | -387.23%(+106.3%) |
| Oct 2014 | - | -187.72%(+47.7%) |
| Jul 2014 | 740.57 K%(<-9900.0%) | -127.10%(+1183.8%) |
| Apr 2014 | - | -9.90%(+106.3%) |
| Jan 2014 | - | -4.80%(+2.6%) |
| Oct 2013 | - | -4.68%(+22.5%) |
| Jul 2013 | -3.95%(-60.2%) | -3.82%(-51.0%) |
| Apr 2013 | - | -7.80%(-23.5%) |
| Jan 2013 | - | -10.19%(+13.2%) |
| Oct 2012 | - | -9.00%(-3.3%) |
| Jul 2012 | -9.92%(+6.9%) | -9.31%(0.0%) |
| Apr 2012 | - | -9.31%(+18.9%) |
| Jan 2012 | - | -7.83%(-35.3%) |
| Oct 2011 | - | -12.10%(-24.8%) |
| Jul 2011 | -9.28%(-85.1%) | -16.10%(-23.2%) |
| Apr 2011 | - | -20.96%(-71.3%) |
| Jan 2011 | - | -73.09%(+7.2%) |
| Oct 2010 | - | -68.19%(-3.3%) |
| Jul 2010 | -62.42%(+165.8%) | -70.55%(+13.9%) |
| Apr 2010 | - | -61.93%(+96.0%) |
| Jan 2010 | - | -31.59%(-14.4%) |
| Oct 2009 | - | -36.90%(-22.5%) |
| Jul 2009 | -23.48%(-13.3%) | -47.64%(+7.3%) |
| Apr 2009 | - | -44.40%(-11.1%) |
| Jan 2009 | - | -49.96%(+31.8%) |
| Oct 2008 | - | -37.90%(+66.2%) |
| Jul 2008 | -27.08%(+3.9%) | -22.81%(+28.9%) |
| Apr 2008 | - | -17.69%(+25.8%) |
| Jan 2008 | - | -14.06%(-27.2%) |
| Oct 2007 | - | -19.31%(-22.5%) |
| Jul 2007 | -26.06%(+141.7%) | -24.93%(+46.2%) |
| Apr 2007 | - | -17.05%(+12.6%) |
| Jan 2007 | - | -15.14%(+149.4%) |
| Oct 2006 | - | -6.07% |
| Jul 2006 | -10.78% | - |
FAQ
- What is BriaCell Therapeutics annual return on equity?
- What is the all time high annual ROE for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual ROE year-on-year change?
- What is BriaCell Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly ROE year-on-year change?
What is BriaCell Therapeutics annual return on equity?
The current annual ROE of BCTX is 201.12%
What is the all time high annual ROE for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual return on equity is 740.57 K%
What is BriaCell Therapeutics annual ROE year-on-year change?
Over the past year, BCTX annual return on equity has changed by -336.38% (-62.58%)
What is BriaCell Therapeutics quarterly return on equity?
The current quarterly ROE of BCTX is 536.28%
What is the all time high quarterly ROE for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly return on equity is 13.19 K%
What is BriaCell Therapeutics quarterly ROE year-on-year change?
Over the past year, BCTX quarterly return on equity has changed by +377.38% (+237.50%)